DIET AND PROBUCOL IN LOWERING CHOLESTEROL CONCENTRATIONS - ADDITIVE EFFECTS ON PLASMA CHOLESTEROL CONCENTRATIONS IN PATIENTS WITH FAMILIAL TYPE 2 HYPERLIPOPROTEINEMIA

被引：88

作者：

LELORIER, J ^{[1
]}

DUBREUILQUIDOZ, S ^{[1
]}

LUSSIERCACAN, S ^{[1
]}

HUANG, YS ^{[1
]}

DAVIGNON, J ^{[1
]}

机构：

[1] CLIN RES INST MONTREAL, MONTREAL H2W 1R7, QUEBEC, CANADA

来源：

ARCHIVES OF INTERNAL MEDICINE | 1977年 / 137卷 / 10期

关键词：

D O I：

10.1001/archinte.137.10.1429

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1429 / 1434

页数：6

共 34 条

[21]

HORLICK L, 1963, J LIPID RES, V4, P160

[22]

KALAMS Z, 1971, CURR THER RES CLIN E, V13, P692

[23] SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].

KANNEL, WB ;

CASTELLI, WP ;

GORDON, T ;

MCNAMARA, PM .

ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+

[24]

KRAML M, 1969, CLIN BIOCHEM, V2, P373, DOI 10.1016/S0009-9120(68)80094-3

[25]

LEES RS, 1963, J LAB CLIN MED, V61, P518

[26] MODE OF ACTION OF A NEW HYPOCHOLESTEREMIC DRUG (DH-581) IN FAMILIAL HYPERCHOLESTEREMIA [J].

MIETTINEN, TA .

ATHEROSCLEROSIS, 1972, 15 (02) :163-+

[27]

MIETTINEN TA, 1976, LIPID PHARMACOLOGY, V2, P120

[28]

MILLER GJ, 1975, LANCET, V1, P16

[29]

NASH DT, 1974, J CLIN PHARMACOL, V14, P470, DOI 10.1002/j.1552-4604.1974.tb02330.x

[30]

PARSONS WB, 1974, ATHEROSCLEROSIS 3, P892

← 1 2 3 4 →